Adam Richardson
- Molecular Biology top 10%
- Cancer Research top 2%
- Immunology top 10%
- Oncology
- Organic Chemistry top 10%
- Co-authors
- Jeffrey W. SmithAndrei L. OstermanDavid A. ScottZe’ev A. RonaiErkki RuoslahtiPriya KarmaliImmo E. SchefflerValentina Fogal
- Topics
- Cancer, Hypoxia, and Metabolism (13 papers)Cancer, Lipids, and Metabolism (6 papers)Metabolomics and Mass Spectrometry Studies (5 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Adam Richardson
33 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 112
- Molecular Biology 1.3k
- Cancer Research 725
- Immunology 311
- Oncology 205
- Organic Chemistry 182
Countries citing papers authored by Adam Richardson
This map shows the geographic impact of Adam Richardson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Richardson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Richardson more than expected).
Fields of papers citing papers by Adam Richardson
This network shows the impact of papers produced by Adam Richardson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Richardson. The network helps show where Adam Richardson may publish in the future.
Co-authorship network of co-authors of Adam Richardson
This figure shows the co-authorship network connecting the top 25 collaborators of Adam Richardson. A scholar is included among the top collaborators of Adam Richardson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Richardson. Adam Richardson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 9 | |
| 4 | 7 | |
| 5 | 7 | |
| 6 | 227 | |
| 7 | 1 | |
| 8 | 153 | |
| 9 | 7 | |
| 10 | 129 | |
| 11 | 157 | |
| 12 | 129 | |
| 13 | 46 | |
| 14 | 270 | |
| 15 | 265 | |
| 16 | 1 | |
| 17 | 72 | |
| 18 | 14 | |
| 19 | 38 | |
| 20 | 197 |
About Adam Richardson
Adam Richardson is a scholar working on Cancer Research, Biotechnology and Pharmaceutical Science, having authored 36 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (13 papers), Cancer, Lipids, and Metabolism (6 papers) and Metabolomics and Mass Spectrometry Studies (5 papers). The work is most often cited by research in Cancer Research (725 citations), Biotechnology (177 citations) and Molecular Biology (1.3k citations). Adam Richardson has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Jeffrey W. Smith, Andrei L. Osterman, David A. Scott, Ze’ev A. Ronai, Erkki Ruoslahti, Priya Karmali, Immo E. Scheffler, Valentina Fogal, Yang Chen and Fabian V. Filipp. Their work appears in journals such as Cell, Journal of the American Chemical Society and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.